Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient

Michael Caspers1, Anna Pavlova, Julia Driesen

  • 1Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.

Insights

Genetic testing effectively diagnoses inherited thrombophilia due to deficiencies in antithrombin (AT), protein C (PC), and protein S (PS). Genetic analysis is recommended for all subnormal AT activities, but not for PC >70% or PS >55%.

Area of Science:

  • Clinical Genetics
  • Hematology
  • Molecular Diagnostics

Background:

  • Inherited thrombophilia is often caused by deficiencies in natural anticoagulant proteins: antithrombin (AT), protein C (PC), and protein S (PS).
  • Understanding the genetic basis of these deficiencies is crucial for accurate diagnosis and clinical management.

Purpose of the Study:

  • To report on the practical experience of genetic analysis in a large cohort of patients with AT, PC, and PS deficiencies.
  • To correlate genetic findings with clinical application and guide diagnostic strategies.

Main Methods:

  • Genotyping of 709 unrelated patients with AT, PC, and PS deficiencies.
  • Mutation detection using direct sequencing and multiplex ligation-dependent probe amplification (MLPA).

Main Results:

  • The highest mutation detection rate (MDR) was observed for the SERPINC1 gene (AT deficiency, 83.5%), followed by PROC (PC deficiency, 69%) and PROS1 (PS deficiency, 43%).
  • For AT deficiency, MDR remained high (70%) even at activities near the normal range (75%).
  • MDR for PC and PS deficiencies dropped significantly at mildly subnormal levels, with no mutations detected for PS at activities >55%.

Conclusions:

  • Genetic testing is a valuable diagnostic tool for thrombophilia.
  • Genetic analysis for AT deficiency is indicated for all subnormal activities.
  • Genotyping for PC activities >70% and PS activities >55% is not advisable due to low mutation detection rates.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...